21 CFR Part 820 (QMSR) Compliance Guide for Medical Device Manufacturers

The U.S. Food and Drug Administration's Quality Management System Regulation (QMSR), codified under 21 CFR Part 820, marks the most significant overhaul of U.S. medical device quality regulations in over 25 years. Published in February 2024 and effective February 2, 2026, the QMSR replaces the legacy Quality System Regulation (QSR) and formally aligns U.S. requirements with ISO 13485:2016, the internationally recognized standard for medical device quality management systems.

For medical device manufacturers operating in the U.S. market, this transition is not optional. Companies that fail to update their QMS to reflect QMSR requirements face warning letters, import alerts, consent decrees, and reputational harm that can halt operations and market access.

This guide is designed for Quality Managers, Regulatory Affairs professionals, QMS Managers, and Heads of Quality who are responsible for driving QMSR compliance inside their organizations. It covers: • What changed from the legacy QSR to the new QMSR • The core regulatory requirements manufacturers must meet • A practical implementation roadmap • Common compliance gaps and how to close them • How a modern, cloud-based QMS accelerates and sustains compliance